Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Although the peptide is reported to be stable in gastric juice, its bioavailability may be lower with this route
GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity
& Kenakin, T
Format Comparison Factor Daily injection burden Pre-blended 1:1 vial 1 injection (combined) Separate vials 12 injections (depending on day) Factor Dose control Pre-blended 1:1 vial Locked at 1:1 BPC-157 : TB-500 Separate vials Independent BPC-157 and TB-500 doses Factor Schedule control Pre-blended 1:1 vial Both compounds on the same schedule Separate vials BPC-157 daily + TB-500 2x/week, etc
Complementary metabolomic and transcriptomic analyses implicated lipogenic, fibrotic and inflammatory pathways, consistent with a unique therapeutic contribution of GCGR agonism by cotadutide in vivo
US$ 29.50
US$ 23.59
US$ 28.10
